NOVAVAX INC (NVAX)
$9.28+$0.23 (+2.54%) Today
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 16 | 283,600 | |
| Option exercise | 12 | 226,560 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
43 Form 4 filings on record, the earliest from Nov 13, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Rachel K. King - Director | Grant or award | Stock Option (Right to Buy) | 28,326 | $6.42 | $182K | |
| Rachel K. King - Director | Grant or award | Restricted Stock Units | 18,884 | $0.00 | - | |
| Gregg H. Alton - Director | Grant or award | Stock Option (Right to Buy) | 28,326 | $6.42 | $182K | |
| Gregg H. Alton - Director | Grant or award | Restricted Stock Units | 18,884 | $0.00 | - | |
 David M. Mott - Director | Grant or award | Stock Option (Right to Buy) | 28,326 | $6.42 | $182K | |
| David M. Mott - Director | Grant or award | Restricted Stock Units | 18,884 | $0.00 | - | |
| Richard J. Rodgers - Director | Grant or award | Stock Option (Right to Buy) | 28,326 | $6.42 | $182K | |
| Richard J. Rodgers - Director | Grant or award | Restricted Stock Units | 18,884 | $0.00 | - | |
| Richard J. Rodgers | Option exercise | Common Stock | 10,420 | $0.00 | - | |
| Richard J. Rodgers | Option exercise | Restricted Stock Units | 10,420 | $0.00 | - | |
| Gregg H. Alton | Option exercise | Common Stock | 10,420 | $0.00 | - | |
| Gregg H. Alton | Option exercise | Restricted Stock Units | 10,420 | $0.00 | - | |
| David M. Mott | Option exercise | Common Stock | 10,420 | $0.00 | - | |
| David M. Mott | Option exercise | Restricted Stock Units | 10,420 | $0.00 | - | |
 Richard Douglas | Option exercise | Common Stock | 10,420 | $0.00 | - | |
| Richard Douglas | Option exercise | Restricted Stock Units | 10,420 | $0.00 | - | |
| Margaret G. McGlynn | Option exercise | Common Stock | 10,420 | $0.00 | - | |
| Margaret G. McGlynn | Option exercise | Restricted Stock Units | 10,420 | $0.00 | - | |
| Rachel K. King | Option exercise | Common Stock | 10,420 | $0.00 | - | |
| Rachel K. King | Option exercise | Restricted Stock Units | 10,420 | $0.00 | - | |
| Charles W. Newton - Director | Grant or award | Stock Option (Right to buy) | 42,840 | $0.00 | - | |
| Charles W. Newton - Director | Grant or award | Restricted Stock Units | 28,560 | $0.00 | - | |
| Mark J. Casey - Officer | Option exercise | Common Stock | 41,900 | $0.00 | - | |
| Mark J. Casey - Officer | Tax withholding / forfeiture | Common Stock | 12,713 | $8.82 | $112K | |
| Mark J. Casey - Officer | Option exercise | Restricted Stock Units | 41,900 | $0.00 | - | |
| Ruxandra Draghia-Akli - Officer | Grant or award | Stock Option (Right to Buy) | 64,150 | $9.01 | $578K | |
| Ruxandra Draghia-Akli - Officer | Grant or award | Restricted Stock Units | 42,770 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 43 NVAX filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
NOVAVAX INC (NVAX) had 8 insider filings in the last 90 days, with the most recent on 2026-06-23. The full record for NVAX runs to 43 Form 4 filings, the earliest from 2024-11-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of NVAX were filed in the last 90 days.
No insider sales of NVAX were filed in the last 90 days.
This page tracks NVAX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NVAX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
